Homology Medicines Inc
NASDAQ:QTTB

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
NASDAQ:QTTB
Watchlist
Price: 2.96 USD -6.92% Market Closed
Market Cap: 36.4m USD

Wall Street
Price Targets

QTTB Price Targets Summary
Homology Medicines Inc

Wall Street analysts forecast QTTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QTTB is 11.56 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Lowest
Price Target
4.04 USD
36% Upside
Average
Price Target
11.56 USD
291% Upside
Highest
Price Target
21 USD
609% Upside
Homology Medicines Inc Competitors:
Price Targets
MDXH
MDxHealth SA
116% Upside
SYNACT
SynAct Pharma AB
28% Upside
ADAG
Adagene Inc
438% Upside
2171
CARsgen Therapeutics Holdings Ltd
48% Upside
DVAX
Dynavax Technologies Corp
96% Upside
KRYS
Krystal Biotech Inc
7% Downside
VCYT
Veracyte Inc
15% Upside
302440
SK Bioscience Co Ltd
25% Downside

Revenue
Forecast

Revenue Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QTTB's stock price target?
Price Target
11.56 USD

According to Wall Street analysts, the average 1-year price target for QTTB is 11.56 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Back to Top